(Q40359728)

English

Immunosuppressive activity of the immunophilin-binding drug Sanglifehrin A in human whole blood: potent inhibition of interleukin-6 produced by lymphocytes and monocytes

scientific article published on January 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Immunosuppressive activity of the immunophilin-binding drug Sanglifehrin A in human whole blood: potent inhibition of interleukin-6 produced by lymphocytes and monocytes (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

1 reference

based on heuristic

inferred from title

author name string

Härtel C

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Iblher P

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Puzik A

3

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Wortmeier K

4

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Ebel B

5

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Schultz C

6

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Müller-Steinhardt M

7

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

publication date

1 January 2006

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Scandinavian Journal of Immunology

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

63

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

26-34

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

The mechanism of action of cyclosporin A and FK506.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01702.X

21 January 2018

When worlds collide: immunosuppressants meet protein phosphatases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01702.X

21 January 2018

Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01702.X

21 January 2018

The novel cyclophilin-binding drug sanglifehrin A specifically affects antigen uptake receptor expression and endocytic capacity of human dendritic cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01702.X

21 January 2018

The effects of cyclosporin A on non-T cell components of the immune system

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01702.X

21 January 2018

Contrasting impacts of immunosuppressive agents (rapamycin, FK506, cyclosporin A, and dexamethasone) on bidirectional dendritic cell-T cell interaction during antigen presentation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01702.X

21 January 2018

Compared to mycophenolate mofetil, rapamycin induces significant changes on growth factors and growth factor receptors in the early days post-kidney transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01702.X

21 January 2018

FK506 potently inhibits T cell activation induced TNF-alpha and IL-1beta production in vitro by human peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01702.X

21 January 2018

Switch from cyclosporine A to tacrolimus in renal transplant recipients: impact on Th1, Th2, and monokine responses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01702.X

21 January 2018

Rapamycin induces apoptosis in monocyte- and CD34-derived dendritic cells but not in monocytes and macrophages

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01702.X

21 January 2018

Transplantation tolerance-where do we stand?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01702.X

21 January 2018

Sanglifehrin-cyclophilin interaction: degradation work, synthetic macrocyclic analogues, X-ray crystal structure, and binding data

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01702.X

21 January 2018

Sanglifehrin A, a novel cyclophilin-binding immunosuppressant, inhibits IL-2-dependent T cell proliferation at the G1 phase of the cell cycle

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01702.X

21 January 2018

Inhibition of cell cycle progression by the novel cyclophilin ligand sanglifehrin A is mediated through the NFkappa B-dependent activation of p53.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01702.X

21 January 2018

Sanglifehrin A, a novel cyclophilin-binding compound showing immunosuppressive activity with a new mechanism of action

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01702.X

21 January 2018

The novel cyclophilin binding compound, sanglifehrin A, disassociates G1 cell cycle arrest from tolerance induction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01702.X

21 January 2018

Cutting edge: sanglifehrin A, a novel cyclophilin-binding immunosuppressant blocks bioactive IL-12 production by human dendritic cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01702.X

21 January 2018

Ex vivo induction of cytokine mRNA expression in human blood samples

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01702.X

21 January 2018

Influence of specimen age and use of different negative controls in determination of intracytoplasmic levels of cytokines after whole-blood culture assay

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01702.X

21 January 2018

Ultraviolet-induced detection of halogenated pyrimidines: simultaneous analysis of DNA replication and cellular markers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01702.X

21 January 2018

Sensitivity of whole-blood T lymphocytes in individual patients to tacrolimus (FK 506): impact of interleukin-2 mRNA expression as surrogate measure of immunosuppressive effect

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01702.X

21 January 2018

Cross-regulation of T cell growth factor expression by p53 and the Tax oncogene

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01702.X

21 January 2018

The immunopathogenesis of sepsis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01702.X

21 January 2018

Sanglifehrins A, B, C and D, novel cyclophilin-binding compounds isolated from Streptomyces sp. A92-308110. II. Structure elucidation, stereochemistry and physico-chemical properties

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.52.474

Identifiers

10.1111/J.1365-3083.2006.01702.X

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40359728&oldid=2127241742"